NCT00332033View on ClinicalTrials.gov

Development of a Non-Invasive Treatment for Uterine Leiomyoma (Fibroids)

PHASE2CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

May 25, 2006

Study Completion Date

February 16, 2007

Conditions
Uterine LeiomyomaFibroids
Interventions
DRUG

Pirfenidone

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

NCT00332033 - Development of a Non-Invasive Treatment for Uterine Leiomyoma (Fibroids) | Biotech Hunter | Biotech Hunter